Dr. Raman Unnikrishnan, MD

Dr. Unnikrishnan practices at Sentara Obici Hospital in Suffolk, Virginia, part of Sentara Health.

Dr. Unnikrishnan's NPI, 1831414739, was assigned on April 2, 2010. Dr. Unnikrishnan graduated from University of Kentucky College of Medicine in 2010. Dr. Unnikrishnan holds Virginia license 0101260018.

Dr. Unnikrishnan's primary practice is Sentara Obici Hospital, at 2800 Godwin Boulevard, Suffolk, VA 23434 in Suffolk City. The practice phone is (757) 934-4000.

Dr. Unnikrishnan's primary practice is Sentara Obici Hospital in Suffolk, Virginia, part of Sentara Health. Dr. Unnikrishnan is also affiliated with Bon Secours Harbour View Medical Center. The medical group on file is Urology of Virginia. Dmand AI also links Dr. Unnikrishnan to 3 more hospitals, 1 group practice or clinic and 1 hospital outpatient department, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Unnikrishnan practices, 7 sites in all. Vendor and product names are available with a free account.

Urology is Dr. Unnikrishnan's primary specialty in the NPI Registry, under taxonomy code 208800000X. Dr. Unnikrishnan is licensed in Virginia.

CMS data shows 16,357 Medicare services from Dr. Unnikrishnan across 41 procedure codes in 2024, for 1,533 Medicare patients. Medicare paid $484,741 for them.

CMS counts 1,533 Medicare patients who saw Dr. Unnikrishnan in 2024. The largest group is 65 to 74, with 662 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 4% are also on Medicaid. Their average risk score is 1.62, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Unnikrishnan's median patient age at 71, with 19% women.

In 2024, Dr. Unnikrishnan wrote 1,104 Medicare Part D claims for 336 patients. 79% of them were for generic drugs. CMS names the drug for 1,000 of them, across 20 drugs with 11 or more claims each, at $2,083,201 in total drug cost. In 2023, CMS named 667 claims across 19 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 79 out of 100 for Dr. Unnikrishnan for performance year 2024, reported as part of a group. Dr. Unnikrishnan accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Unnikrishnan as offering telehealth.

Prostate resection: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 8 papers to Dr. Unnikrishnan, published from 2011 to 2018. 2015 was the busiest year, with 3. Dr. Unnikrishnan has published most often in Urology. Dr. Unnikrishnan's most frequent co-authors are Steven Campbell, MD, Khaled Fareed, MD and Amr F. Fergany, MD.

CMS Open Payments shows 346 general payments to Dr. Unnikrishnan from 46 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 76% of the total. Janssen Pharmaceuticals, Inc paid the most, $2,817.

Dr. Unnikrishnan graduated from University of Kentucky College of Medicine in 2010.